XGen Ventures logo

XGen Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series C

Nouscom logo
Nouscom

Clinical-stage immuno-oncology • Cancer immunotherapies

XGen Ventures logo
Versant Ventures logo
Revelation Partners logo
Panakès Partners logo

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.

Series C
$72.5M
11/14/2023
Article